Petros Pharmaceuticals, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
Petros Pharmaceuticals, Inc. (PTPI) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 2.18 thousand shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-04-15
- Petros Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2022-12-31 was -67.50K shares.
- Petros Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2022-09-30 was 0.00 shares.
- Petros Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 2.18K shares, a 38.76% decline from fiscal 2024.
- Petros Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 3.56K shares, a 28.80% decline from fiscal 2023.
- Petros Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 5.00K shares, a 33.33% decline from fiscal 2022.
- Petros Pharmaceuticals, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 7.50K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | 2.18K shares 10-K · filed 2026-04-15 | ||||
| 2024-12-31 | 3.56K shares 10-K · filed 2026-04-15 | 89.00K shares 10-K · filed 2025-03-31 | |||
| 2023-12-31 | 5.00K shares 10-K · filed 2025-03-31 | ||||
| 2022-12-31 | -67.50K shares derived: 10-K 12 month − 10-Q/A 9 month · filed 2023-03-31 | -67.50K shares derived: sum of 2 quarters · filed 2023-03-31 | 7.50K shares 10-K · filed 2023-03-31 | ||
| 2022-09-30 | 0.00 shares derived: 10-Q/A 9 month − 10-Q 6 month · filed 2022-11-15 | 75.00K shares 10-Q/A · filed 2022-11-15 | |||
| 2022-06-30 | 75.00K shares 10-Q · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B |